Epidemiological Study of the Incidence of Cancers Eligible for Proton or Carbon Ions Therapy: Methodology and Results of Recruitment Estimation

Table 2

Results, EpiHadron study: summary of incidence rates calculated during hadrontherapy epidemiological studies conducted between 1998 and 2004.

Country	Gross incidence/year*	Incidence/; /100,000 inhabitants/year*	Total population during the year of the study (ù)	Study year	Related healthcare centre
Italy	10,825	19	56 908 265	1998	CNAO
Austria	4873	61	7 982 461	1999	Med-AUSTRON
Switzerland	263	4	7 123 537	1999	Med-AUSTRON
Slovenia (a)	626	31	2 000 092	1999	Med-AUSTRON
Hungary	153	1	10 253 400	1999	Med-AUSTRON
Italy	313	1	56 913 634	1999	Med-AUSTRON
Czech Republic (b)	5060	50	10 190 000	1999	Med-AUSTRON
Slovakia (y)	1734	32	5 477 038	1999	Med-AUSTRON
France	5320	9	61 424 036	2002	ETOILE
Austria	2044	25	8 063 640	2002	Med-AUSTRON
Italy	5579	10	57 888 245	2004	CNAO

∗Estimate expressed in study population, irrespective of disease location.
(y, a, b) Estimate of 2011, no data available before this date.
(ù) Demographic sources.
http://www.statistiques-mondiales.com.
http://appsso.eurostat.ec.europa.eu/nui/setupModifyTableLayout.do.
http://www.diplomatie.gouv.fr.